Primary ciliary dyskinesia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:244OMIM:620032Q34.8
Who is this for?
Show terms as
17Active trials44Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Primary ciliary dyskinesia (PCD), also known as immotile cilia syndrome or Kartagener syndrome (when accompanied by situs inversus), is a rare inherited disorder affecting the structure and/or function of motile cilia — tiny hair-like projections that line the airways, middle ear, reproductive tract, and embryonic node. Defective ciliary motility leads to impaired mucociliary clearance in the respiratory tract, resulting in chronic and recurrent upper and lower respiratory infections. The hallmark clinical features include neonatal respiratory distress, chronic wet cough beginning in early childhood, recurrent sinusitis, chronic otitis media with effusion often leading to hearing impairment, and progressive bronchiectasis. Approximately 50% of individuals with PCD have situs inversus totalis (mirror-image reversal of internal organs), and a smaller subset may have heterotaxy with associated congenital heart defects, reflecting the role of nodal cilia in establishing left-right body asymmetry during embryonic development. PCD is caused by pathogenic variants in genes encoding ciliary structural proteins, assembly factors, or regulatory components. Over 50 causative genes have been identified to date, including DNAI1, DNAH5, DNAH11, CCDC39, CCDC40, and many others. The diagnosis is established through a combination of clinical suspicion, nasal nitric oxide measurement (characteristically very low in PCD), high-speed video microscopy of ciliary beat pattern, transmission electron microscopy of ciliary ultrastructure, immunofluorescence staining of ciliary proteins, and genetic testing. No single test is sufficient for diagnosis, and a multi-test approach is recommended. There is currently no cure for PCD, and no approved therapies specifically target the underlying ciliary defect. Management is largely supportive and borrows from cystic fibrosis care paradigms, focusing on aggressive airway clearance techniques (chest physiotherapy, exercise), prompt treatment of respiratory infections with antibiotics, and regular monitoring of lung function. Hearing aids may be needed for conductive hearing loss, and surgical interventions such as tympanostomy tubes or sinus surgery may be considered in selected cases. Fertility may be affected in both males (due to dysmotile sperm) and females (due to impaired ciliary function in the fallopian tubes), though assisted reproductive technologies can be successful. Early diagnosis and proactive management are essential to slow the progression of lung disease and preserve quality of life.

Also known as:

Clinical phenotype terms— hover any for plain English:

Nasal congestionHP:0001742Chronic rhinitisHP:0002257Recurrent sinopulmonary infectionsHP:0005425Chronic sinusitisHP:0011109Respiratory tract infectionHP:0011947Abnormal sperm motilityHP:0012206Productive coughHP:0031245Abnormal sputumHP:0032016Nasal polyposisHP:0100582ClubbingHP:0001217
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

10 events
Jun 2026Evaluation of C-arm PCD-CBCT for Image-Guided Interventions

University of Wisconsin, Madison

TrialNOT YET RECRUITING
May 2026Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases

University of Thessaly — NA

TrialNOT YET RECRUITING
Apr 2026Prostate Stereotactic Radiation and Radio-induced Lymphocyte Apoptosis for Predicting Late Toxicities in Prostate Cancer (PROSTERA)

Clinique Sainte Clotilde — NA

TrialNOT YET RECRUITING
Mar 2026Inhibiting the Anti-apoptotic Factor, BCL-2, at the Time of ART Initiation to Promote Apoptosis of HIV-infected Cells and Restrict the Seeding of the HIV Reservoir: An Investigator-initiated Randomised, Controlled, Open-label Clinical Trial (The INITIATE Study)

Thomas Aagaard Rasmussen — PHASE1

TrialNOT YET RECRUITING
Jan 2026Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

Corcept Therapeutics — PHASE1, PHASE2

TrialRECRUITING
Jan 2026Evaluation of the Ketogenic Diet to Improve Post Operative Cognitive Decline in Cardiac Surgery

University of Missouri-Columbia — NA

TrialNOT YET RECRUITING
Jan 2026Association of BAL Fluid T-Cell Immune Activity With Tumor PD-L1 Expression and Its Prognostic Value: A Prospective Observational Study

Seoul National University Hospital

TrialNOT YET RECRUITING
Oct 2025Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia

Instituto Nacional de Enfermedades Respiratorias — NA

TrialRECRUITING
Sep 2025Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia

Association Francaise pour la Recherche Thermale — NA

TrialRECRUITING
Sep 2025A Qualitative Study Investigating the Lived Experiences and Impact of Reproductive Issues in Adults With Primary Ciliary Dyskinesia

University Hospital Southampton NHS Foundation Trust

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Primary ciliary dyskinesia.

17 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

17 recruitingView all trials with filters →
Phase 11 trial
Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance
Phase 1
Active
PI: John Matthews, MBBS, MCRP, PhD (ReCode Therapeutics, Inc.) · Sites: Chapel Hill, North Carolina; Copenhagen +1 more · Age: 1875 yrs
N/A6 trials
Chest Physiotherapy and Lung Function in Primary Ciliary Dyskinesia
N/A
Actively Recruiting
PI: Mieke Boon, MD (research fellow) · Sites: Leuven · Age: 650 yrs
Utility of PCD Diagnostics to Improve Clinical Care
N/A
Actively Recruiting
· Sites: Nashville, Tennessee · Age: 199 yrs
DCP (RaDiCo Cohort) (RaDiCo-DCP)
N/A
Actively Recruiting
PI: Bernard MAITRE (INSERM UMR 955) · Sites: Besançon; Bordeaux +18 more
Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia
N/A
Actively Recruiting
PI: Mario H. Vargas, MSc (5556665868) · Sites: Mexico City · Age: 599 yrs
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
N/A
Actively Recruiting
· Sites: Indianapolis, Indiana · Age: 699 yrs
Thermal Spa Treatment and Improvement of Primary Ciliary Dyskinesia
N/A
Actively Recruiting
PI: Colin DEBAIGT · Sites: Nice · Age: 1899 yrs
Other10 trials
International Primary Ciliary Dyskinesia Cohort
Active
PI: Claudia E Kuehni, Prof (University of Bern) · Sites: Bern
International Primary Ciliary Dyskinesia (PCD) Registry
Actively Recruiting
· Sites: Münster, North Rhine-Westphalia; Münster
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials
Active
PI: John G. Matthews, MBBS, MRCP, PhD (ReCode Therapeutics, Inc.) · Sites: Menlo Park, California · Age: 1899 yrs
Utility of PCD Diagnostics to Improve Clinical Care
Actively Recruiting
PI: Melanie S Collins, MD (Connecticut Children's Medical Center) · Sites: Hartford, Connecticut · Age: 299 yrs
A Qualitative Study Investigating the Lived Experiences and Impact of Reproductive Issues in Adults With Primary Ciliary Dyskinesia
Actively Recruiting
· Sites: Southampton · Age: 1899 yrs
Living With Primary Ciliary Dyskinesia (Living With PCD)
Actively Recruiting
PI: Claudia E Kuehni, Prof. (University of Bern) · Sites: Bern
Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
Actively Recruiting
· Sites: Little Rock, Arkansas · Age: 299 yrs
A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults
Active
PI: Priya Ryali (ReCode Therapeutics) · Sites: Chapel Hill, North Carolina · Age: 1860 yrs
The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)
Actively Recruiting
PI: Myrofora Goutaki, MD-PhD (University of Bern) · Sites: Bern
Swiss Primary Ciliary Dyskinesia Registry
Actively Recruiting
PI: Claudia E Kuehni, Prof (University of Bern) · Sites: Bern

Specialists

Showing 25 of 44View all specialists →
BM
Bernard MAITRE
Besançon
Specialist

Rare Disease Specialist

PI on 1 active trial7 Primary ciliary dyskinesia publications
HM
Heymut Omran, MD
Specialist
PI on 1 active trial
HM
Heather Landau, MD
NEW YORK, NY
Specialist
PI on 4 active trials
MM
Margaret W Leigh, MD
CHAPEL HILL, NC
Specialist
PI on 1 active trial
UO
Ugur Ozcelik
Specialist
PI on 1 active trial32 Primary ciliary dyskinesia publications
NE
Nagehan Emiralioglu
Specialist
PI on 1 active trial11 Primary ciliary dyskinesia publications
CP
Claudia E Kuehni, Prof
Specialist
PI on 2 active trials
MM
Margaret Rosenfeld, MD
EVANSTON, IL
Specialist
PI on 1 active trial
RM
Ronald G Crystal, MD
NEW YORK, NY
Specialist
PI on 12 active trials
BS
Birce Sunman
Specialist
PI on 1 active trial2 Primary ciliary dyskinesia publications
HS
Hazal Sonbahar-Ulu
Specialist
PI on 1 active trial
AC
Aslihan Cakmak
Specialist
PI on 1 active trial6 Primary ciliary dyskinesia publications
NV
Naciye Vardar-Yagli
Specialist
PI on 1 active trial2 Primary ciliary dyskinesia publications
MS
Melda Saglam
Specialist
PI on 1 active trial18 Primary ciliary dyskinesia publications
FM
Felix Ratjen, MD
Specialist
PI on 4 active trials
SR
Steven M Rowe
Specialist
PI on 1 active trial13 Primary ciliary dyskinesia publications
ŞM
Şeyma Mutlu, MD
Specialist
PI on 1 active trial
EC
Ebru Calik-Kutukcu
Specialist
PI on 1 active trial1 Primary ciliary dyskinesia publication
KM
Kenneth Olivier, MD, MPH
ROCHESTER, MN
Specialist
PI on 1 active trial
MP
Marián Pérez-Marín, PhD
Specialist
PI on 2 active trials
BM
Betül Yoleri, MD
Specialist
PI on 1 active trial
KS
Kim G Nielsen, Dr Med Sci
Specialist
PI on 1 active trial
LP
Lawrence Ostrowski, PhD
CINCINNATI, OH
Specialist
PI on 1 active trial
KM
Kenneth R. Olivier, MD, MPH
ROCHESTER, MN
Specialist
PI on 1 active trial

Treatment Centers

8 centers
⚗️ Trial Site

CHU de Caen

📍 Caen

⚗️ Trial Site

Hôpital de la Timone

📍 Marseille

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

Travel Grants

No travel grants are currently matched to Primary ciliary dyskinesia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Primary ciliary dyskinesiaForum →

No community posts yet. Be the first to share your experience with Primary ciliary dyskinesia.

Start the conversation →

Latest news about Primary ciliary dyskinesia

1 articles
ResearchPUBMEDMar 26, 2026
Rare Pediatric Pulmonary Diseases: Insights from a Survey of Pediatric Pulmonologists in German-Speaking Countries.
Doctors who treat children with rare lung diseases in German-speaking countries were surveyed about their experience and confidence in diagnosing and treating t
See all news about Primary ciliary dyskinesia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Primary ciliary dyskinesia

What is Primary ciliary dyskinesia?

Primary ciliary dyskinesia (PCD), also known as immotile cilia syndrome or Kartagener syndrome (when accompanied by situs inversus), is a rare inherited disorder affecting the structure and/or function of motile cilia — tiny hair-like projections that line the airways, middle ear, reproductive tract, and embryonic node. Defective ciliary motility leads to impaired mucociliary clearance in the respiratory tract, resulting in chronic and recurrent upper and lower respiratory infections. The hallmark clinical features include neonatal respiratory distress, chronic wet cough beginning in early chi

How is Primary ciliary dyskinesia inherited?

Primary ciliary dyskinesia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Primary ciliary dyskinesia typically begin?

Typical onset of Primary ciliary dyskinesia is neonatal. Age of onset can vary across affected individuals.

Are there clinical trials for Primary ciliary dyskinesia?

Yes — 17 recruiting clinical trials are currently listed for Primary ciliary dyskinesia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Primary ciliary dyskinesia?

25 specialists and care centers treating Primary ciliary dyskinesia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.